Prediction of oral bioavailability by adaptive fuzzy partitioning

European Journal of Medicinal Chemistry

Volumn 38, Issue 4, 2003, Pages 427-431

  Pintore, Marco ^a   Van De Waterbeemd, Han ^b   Piclin, Nadège ^a   Chrétien, Jacques R ^a  

^a BioChemics Consulting   (France)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

Author keywords

Database mining; Fuzzy logic; Molecular diversity; Oral bioavailability

Indexed keywords

ADAPTIVE FUZZY PARTITIONING; ALGORITHM; COMBINATORIAL CHEMISTRY; CONFERENCE PAPER; DRUG BIOAVAILABILITY; MODEL; PREDICTION; VALIDATION PROCESS;

EID: 0038393246     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00052-7     Document Type: Conference Paper

References (36)

1. Lowe G. Chem. Soc. Rev. 24:1995;309-317.
2. Borman S. C&EN. 77:1999;33-48.
3. Eddershaw P.J., Beresford A.P., Bayliss M.K. DDT. 5:2000;409-414.
4. Li A.P. DDT. 6:2001;357-366.
5. Stenberg P., Luthman K., Artursson K. J. Control Release. 65:2000;231-243.
6. Ekins S., Waller C.L., Swaan P.W., Cruciani G., Wrighton S.A., Wikel J.H. J. Pharm. Tox. Methods. 44:2000;251-272.
7. Clark D.E., Pickett S.D. DDT. 5:2000;49-58.
8. Ekins S., Rose J. J. Mol. Graph. Model. 20:2002;305-309.
9. G. Klopman, L. Stefan, R.D. Saiakhov, Proceedings of the 223rd American Chemical Society National Meeting, ACS, Washington DC, USA, 2000.
10. Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Adv. Drug Deliv. Rev. 46:2001;3-26.
11. Veber D.F., Johnson S.R., Cheng H.-Y., Smith B.R., Ward K.W., Kopple K.D. J. Med. Chem. 45:2002;2615-2623.
12. Yoshida F., Topliss J.G. J. Med. Chem. 43:2000;2575-2585.
13. Andrews C.W., Bennett L., Yu L.X. Pharm. Res. 17:2000;639-644.
14. Bains W., Gilbert R., Sviridenko L., Gascon J.-M., Scoffin R., Birchall K., Harvey I., Caldwell J. Curr. Opin. Drug Discovery Dev. 5:2002;44-51.
15. Zadeh L.A. Van Ryzin J. Classification and Clustering. 1977;251-299 Academic Press, NY, USA.
16. Pintore M., Audouze K., Ros F., Chretien J.R. Data Sci. J. 1:2002;99-110.
17. M. Pintore, N. Piclin, E. Benfenati, G. Gini, J.R. Chrétien, Env. Tox. Chem. 22 (2003), in press.
18. Pintore M., Taboureau O., Ros F., Chrétien J.R. Eur. J. Med. Chem. 36:2001;349-359.
19. Hirono S., Nakagome I., Hirano H., Matsushita Y., Yoshi F., Moriguchi I. Biol. Pharm. Bull. 17:1994;306-309.
20. Ros F., Pintore M., Chrétien J.R. Chemometr. Intell. Lab. 63:2002;15-26.
21. Bertz R.J., Granneman G.R. Clin. Pharmacokinet. 32:1997;210-258.
22. L.S. Goodman, L.E. Limbird, P.B. Milinoff, A.G. Gilman, J.G. Hardman (Eds.), Goodman and Gilman's: the pharmacological basis of therapeutics, ninth ed., Mc-Graw-Hill, New York, NY, USA.
23. Navia M.A., Chaturvedi P.R. DDT. 1:1996;179-189.
24. Sietsema W.K. Int. J. Clin. Ther. Tox. 27:1989;179-211.
25. Sabljic A. Karcher W., Devillers J. Practical Applications of Quantitative Structure-Activity Relationships (QSAR) in Environmental Chemistry and Toxicology. 1990;61-82 Kluwer Academic Publishers, Dordrecht.
26. Dearden J.C. Karcher W., Devillers J. Practical Applications of Quantitative Structure-Activity Relationships (QSAR) in Environmental Chemistry and Toxicology. 1990;25-59 Kluwer Academic Publishers, Dordrecht.
27. Kier L.B., Hall L.K. Molecular Structure Description - The Electrotopological State. 1999;Academic Press, San Diego, CA, USA.
28. Haupt R.L., Haupt S.E. Practical Genetic Algorithms. 1998;Wiley, NY, USA.
29. Leardi R., Gonzales A.L. Chemometr. Intell. Lab. 1998;195-207.
30. Lin Y., Cunninghan G.J. J. Intell. Fuzzy Syst. 2:1994;243-250.
31. Sugeno M., Yasakawa T. IEEET. Fuzzy Syst. 1:1993;7-31.
32. Dubois D., Prade H. Shafer G., Pearl J. Readings in Uncertain Reasoning, Morgan Kaufmann. 1990;742-761 San Francisco, CA, USA.
33. Gupta M.M., Qi J. Fuzzy Set Syst. 40:1991;431-450.
34. Kohonen T. Self-Organizing Maps. 2001;Springer, New York, NY, USA.
35. Cruciani G., Crivori P., Carrupt P.-A., Testa B. J. Mol. Struct. (Theochem.). 503:2000;17-30.
36. Oprea T.I., Zamora I., Ungell A.L. J. Comb. Chem. 4:2002;258-266.